xabarchixabarchiABARCHI
Uzbekistan

The Ministry of Health signed a contract with a Korean company to establish a new oncology center

The Ministry of Health has signed a contract with a Korean company for the construction of a new oncology center

In Tashkent, a contract for consulting services was signed as part of the project to build a new 265-bed oncology center. This facility will become a significant part of the medical cluster being created in the capital jointly with the Export-Import Bank of Korea.

According to the press service of the Ministry of Health, the document was signed by Minister of Health Eldor Adilov and Lee Won-seok, Vice President of the Korean company AUM & LEE Architects & Associates. During the meeting, the parties discussed further stages of construction.

The AUM & LEE consortium will provide consultations on design, construction management and control, selection of medical equipment, as well as planning of medical services and the information system.

A three-stage practical training program on the quality of medical services, radiology, nuclear medicine, and radiation therapy is planned for the center's staff. The Minister emphasized the importance of high-quality construction of the center and expressed confidence in the experience of the Korean side.

In September, an official ceremony was held to launch joint Uzbek-Korean production facilities and begin the construction of several major projects. President Shavkat Mirziyoyev and Prime Minister of the Republic of Korea Han Duck-soo took part in it. It was reported that along with other projects, the construction of the National Oncology Center and a higher medical educational institution has started in Tashkent.

Cookies on xabarchi

We use cookies to remember your language and theme, and to count how many people are reading right now — that count is anonymous, lasts only while your browser is open, and cannot be tied to you or to another visit. With your permission we also measure how the site is read: Microsoft Clarity, which records page views and on-page interactions, and our own count of returning readers. Nothing that recognises you across visits is measured until you accept.